Goelzer Investment Management’s Pacira BioSciences PCRX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | – | Sell |
-31,495
| Closed | -$1.84M | – | 230 |
|
2022
Q2 | $1.84M | Buy |
31,495
+290
| +0.9% | +$16.9K | 0.18% | 129 |
|
2022
Q1 | $2.38M | Buy |
31,205
+11,276
| +57% | +$861K | 0.21% | 123 |
|
2021
Q4 | $1.2M | Sell |
19,929
-728
| -4% | -$43.8K | 0.1% | 154 |
|
2021
Q3 | $1.16M | Sell |
20,657
-544
| -3% | -$30.5K | 0.1% | 155 |
|
2021
Q2 | $1.29M | Buy |
21,201
+196
| +0.9% | +$11.9K | 0.11% | 156 |
|
2021
Q1 | $1.47M | Sell |
21,005
-1,161
| -5% | -$81.4K | 0.13% | 152 |
|
2020
Q4 | $1.33M | Sell |
22,166
-111
| -0.5% | -$6.64K | 0.12% | 150 |
|
2020
Q3 | $1.34M | Buy |
+22,277
| New | +$1.34M | 0.12% | 156 |
|